Suja Life, Inc. (SUJA) AI Stock Analysis

Suja Life, Inc. engages in the production and selling of organic and cold-pressed juices and wellness shots in the United States. Founded in 2012 and headquartered in Oceanside, California, the company employs 590 people following its 2026 IPO. It offers cold-pressed juices and wellness shots in various flavors under the Suja Organic brand name, wellness shots under the Vive Organic brand name, and soda made with real fruit juices under the Slice brand name. Suja Life distributes its products through a network of distributors and retail stores, as well as via online channels.

Annual revenue increased from $224.4M in FY2023 to $258.9M in FY2024, representing 15.4% growth, before expanding 26.1% to $326.6M in FY2025. Gross margin rose from 44.5% in FY2023 to 49.5% in FY2024, then stood at 48.1% in FY2025. Operating margin fluctuated from -3.7% in FY2023 to 0.2% in FY2024 and -5.6% in FY2025. Net income remained negative across all three years, posting -$24.5M in FY2023, -$20.8M in FY2024, and -$21.3M in FY2025. For the trailing twelve months ended June 30, 2026, revenue totaled $355.0M with quarterly revenue growth of 11.6% year-over-year, an operating margin of 5.4%, and a profit margin of -10.4%.

As of June 30, 2026, Suja Life held $20.6M in cash and short-term investments alongside total debt of $191.6M, resulting in net debt of $171.0M. Shareholders' equity was $117.6M against total assets of $419.0M, yielding a debt-to-equity ratio of 1.63 and a current ratio of 1.53. In FY2025, operating cash flow was $8.3M, capital expenditures were $14.1M, and free cash flow was -$5.8M, compared to positive free cash flow of $7.0M in FY2023 and $158,000 in FY2024. Cash flow use in FY2025 also included dividends paid of $1.8M.

Suja Life trades at an enterprise value of $363.0M and a market capitalization of $444.2M. The stock trades at a price-to-sales multiple of 1.3x and an ev_to_revenue of 1.0x, compared to a price-to-sales ratio of 0.7x for the median of its US-listed Consumer Defensive peers. Its ev_to_ebitda multiple is 30.0x, well above the peer median of 11.7x. The company has a price-to-book ratio of 1.6x. Following its 2026 IPO, the shares closed at $11.50 on October 16, 2026, within a 52-week range of $5.59 to $18.48.

Wall Street coverage consists of 4 Strong Buy ratings and 3 Hold ratings, with 0 Buy, Sell, or Strong Sell ratings. The mean price target is $18.40, representing an upside of 60.0% from the last close of $11.50. For the fiscal year ending December 31, 2026, analysts estimate revenue of $361.7M and EPS of $0.27. For the next fiscal year, 3 analysts project revenue of $407.3M, reflecting revenue growth of 12.6%, and EPS of $0.42, which represents EPS growth of 57.2%.

This page is an AI-written research summary of Suja Life, Inc. (SUJA). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: SUJA income statement, SUJA balance sheet, SUJA key metrics, SUJA analyst forecast, SUJA chart. See the SUJA stock overview for the latest quote and news.